Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20200724048188N1Phase 2Completed
Phase 2, triple-blind trial of articaine, lidocaine and epinephrine (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoints: Systolic blood pressure and Diastolic blood pressure. Started Oct 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20200724048188N1.